Dimensional Fund Advisors LP Regenxbio Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,150,188 shares of RGNX stock, worth $8.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,150,188

Previous 1,107,453 3.86%

Holding current value

$8.76 Million

Previous $13 Million 6.88%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$10.49 - $14.39 $448,290 - $614,956	42,735 Added 3.86%	1,150,188 $12.1 Million
Q2 2024 Aug 09, 2024	SELL	$11.51 - $21.53 $1.03 Million - $1.93 Million	-89,620 Reduced 7.49%	1,107,453 $13 Million
Q1 2024 May 10, 2024	SELL	$12.17 - $24.61 $363,688 - $735,445	-29,884 Reduced 2.44%	1,197,073 $25.2 Million
Q4 2023 Feb 07, 2024	BUY	$12.89 - $20.82 $443,222 - $715,895	34,385 Added 2.88%	1,226,957 $22 Million
Q3 2023 Nov 09, 2023	SELL	$16.46 - $19.99 $3.22 Million - $3.91 Million	-195,442 Reduced 14.08%	1,192,572 $19.6 Million
Q2 2023 Aug 09, 2023	SELL	$17.23 - $21.71 $2.55 Million - $3.22 Million	-148,117 Reduced 9.64%	1,388,014 $27.7 Million
Q1 2023 May 12, 2023	BUY	$18.08 - $24.55 $3.19 Million - $4.33 Million	176,543 Added 12.99%	1,536,131 $29 Million
Q4 2022 Feb 09, 2023	BUY	$20.4 - $24.73 $2.15 Million - $2.61 Million	105,487 Added 8.41%	1,359,588 $30.8 Million
Q3 2022 Nov 10, 2022	BUY	$22.29 - $35.04 $3.94 Million - $6.19 Million	176,607 Added 16.39%	1,254,101 $33.1 Million
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $5.77 Million - $10.5 Million	298,352 Added 38.29%	1,077,494 $26.6 Million
Q1 2022 May 13, 2022	BUY	$24.62 - $34.31 $730,475 - $1.02 Million	29,670 Added 3.96%	779,142 $25.9 Million
Q4 2021 Feb 09, 2022	BUY	$30.19 - $40.28 $2.5 Million - $3.33 Million	82,730 Added 12.41%	749,472 $24.5 Million
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $8.29 Million - $13 Million	-285,141 Reduced 29.96%	666,742 $28 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $40.48 $4.05 Million - $5.04 Million	124,616 Added 15.06%	951,883 $37 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $4.57 Million - $6.78 Million	135,823 Added 19.64%	827,267 $28.2 Million
Q4 2020 Feb 25, 2021	BUY	$26.52 - $49.35 $18.3 Million - $34.1 Million	691,444 New	691,444 $31.4 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Regenxbio Inc. Transaction History